IntelGenx Technologies Corp. IGXT OTC

Other OTC • Healthcare • Biotechnology • CA • USD

SharesGrow Score

21/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

IntelGenx Technologies Corp. (IGXT) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 20/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

21/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

✓

FUTURE

100/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — IGXT

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio28.58

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.06

Book Value / Share$0.00

Revenue / Share$0.01

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$-0.03	$1.66M	$-1.75M	-105.2%
2015	$0.01	$5.1M	$1.29M	25.3%
2016	$-0.02	$5.22M	$-1.18M	-22.6%
2017	$-0.05	$5.2M	$-3.05M	-58.7%
2018	$-0.14	$1.82M	$-10.11M	-554.2%
2019	$-0.13	$742K	$-11.87M	-1599.3%
2020	$-0.08	$1.54M	$-8.25M	-534.1%
2021	$-0.07	$1.54M	$-9.31M	-606.6%
2022	$-0.07	$950K	$-11.97M	-1259.7%
2023	$-0.06	$1.04M	$-9.93M	-955.4%